Influenza virus receptors on human airway epithelial cells
Influenza virus receptors on human airway epithelial cells
批准号:
10676798
负责人:
JAMES C PAULSON
金额:
$60.64万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-03 至 2024-07-31
关键词:
AgglutininsAntibodiesAvian Influenza A VirusAvidityBindingBiological AssayBiologyBirdsCellsChickensDropsEndothelial CellsEnzyme-Linked Immunosorbent AssayEpithelial CellsEpithelial Receptor CellEquilibriumErythrocytesEvolutionExhibitsGalanthusGleanGoalsGrowthHemagglutininHorseradish PeroxidaseHumanHuman ActivitiesImmuneImmunodominant EpitopesInfectionInfluenzaInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza HemagglutininKineticsKnowledgeLaboratoriesLibrariesLinkMDCK cellMeleagris gallopavoMethodsModelingMutationN-acetyllactosamineNasal EpitheliumNeuraminidaseNosePolysaccharidesPopulationProductionPropertyProteinsRecombinantsRecoveryRoleST14 geneSeasonsSialic AcidsSoft PalateSpecificitySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStructureSurface AntigensSurveysTimeTracheaTracheal EpitheliumVaccine ProductionVaccinesVariantVirusVirus Receptorsairway epitheliumcandidate identificationchorioallantoic membraneeggfitnessflu activityimprovedinfluenzavirusmortalitynovelpandemic diseasepandemic potentialpreferencepressurereceptorreceptor bindingtooltransmission processvaccine efficacy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Influenza virus causes worldwide seasonal infections and occasional pandemics with high mortality rate.
Human viruses are known to have a preference for α2-6 linked sialic acids (NeuAcα2-6Gal), while avian
viruses exhibit a preference for α2-3 linked sialic acids (NeuAcα2-3Gal). This difference in receptor specificity
is widely considered a major species barrier for transmission of avian viruses in the human population.
Although this binary model of receptor specificity has been useful, it belies the true complexity of sialic acid
containing glycans on host cells and has becoming increasingly limiting since the receptor binding properties
of influenza viruses continue to evolve. The use of glycan microarrays with dozens of α2-3 and α2-6 linked
glycans has shown that influenza viruses evolve by restricting their specificity to specific glycans within those
broad groups. However, interpretation of these findings for their relevance to influenza biology is uncertain
since there is little information about the types of glycans that are actually present on human airway
epithelium, and whether relevant airway epithelium glycans are represented on glycan microarrays. This
project aims to identify the glycan structures on human airway epithelial cells that bind human influenza virus
and expand glycan array libraries to include them, 2) to determine how the specificity and activity of human
influenza virus hemagglutinins (HAs) and neuraminidases (NAs) evolve under immune selective pressure to
retain their ability to interact with human airway receptors and 3) to use the information gleaned about
receptor specificity to develop reliable methods for analysis and propagation of influenza in the laboratory.
This information will identify receptor determinants on the human airway that are shared by human influenza
viruses, and shed light on properties of the HA and NA that contribute to pandemic risk of influenza viruses
from avian viruses that occasionally infect humans.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.15252/emmm.201707726
发表时间:
2017-09
期刊:
EMBO molecular medicine
影响因子:
11.1
作者:
[de Vries RP, Tzarum N, Peng W, Thompson AJ, Ambepitiya Wickramasinghe IN, de la Pena ATT, van Breemen MJ, Bouwman KM, Zhu X, McBride R, Yu W, Sanders RW, Verheije MH, Wilson IA, Paulson JC]
通讯作者:
Paulson JC
DOI:
10.1021/jacsau.2c00664
发表时间:
2023-03-27
期刊:
JACS AU
影响因子:
8
作者:
[Canales, Angeles, Sastre, Javier, Orduna, Jose M, Spruit, Cindy M, Perez-Castells, Javier, Dominguez, Gema, Bouwman, Kim M, van der Woude, Roosmarijn, Canada, Francisco Javier, Nycholat, Corwin M, Paulson, James C, Boons, Geert-Jan, Jimenez-Barbero, Jesus, de Vries, Robert P]
通讯作者:
de Vries, Robert P
DOI:
10.3389/fimmu.2022.987151
发表时间:
2022
期刊:
FRONTIERS IN IMMUNOLOGY
影响因子:
7.3
作者:
[Van Coillie, Julie, Schulz, Morten A., Bentlage, Arthur E. H., de Haan, Noortje, Ye, Zilu, Geerdes, Dionne M., van Esch, Wim J. E., Hafkenscheid, Lise, Miller, Rebecca L., Narimatsu, Yoshiki, Vakhrushev, Sergey Y., Yang, Zhang, Vidarsson, Gestur, Clausen, Henrik]
通讯作者:
Clausen, Henrik
DOI:
10.1016/j.celrep.2017.03.054
发表时间:
2017-04-11
期刊:
Cell reports
影响因子:
8.8
作者:
[Tzarum N, de Vries RP, Peng W, Thompson AJ, Bouwman KM, McBride R, Yu W, Zhu X, Verheije MH, Paulson JC, Wilson IA]
通讯作者:
Wilson IA
DOI:
10.1016/j.chom.2016.11.004
发表时间:
2017-01-11
期刊:
Cell host & microbe
影响因子:
30.3
作者:
[Peng W, de Vries RP, Grant OC, Thompson AJ, McBride R, Tsogtbaatar B, Lee PS, Razi N, Wilson IA, Woods RJ, Paulson JC]
通讯作者:
Paulson JC
共 20 条
Removing sialic acid ligands of CD28 to enhance T cell cancer immunotherapy
-
批准号:10668007
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2023
-
负责人:JAMES C PAULSON
-
依托单位:
Siglec-targeted nanoparticles for treating mast cell mediated allergic disease
-
批准号:10331726
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2018
-
负责人:JAMES C PAULSON
-
依托单位:
Exploiting inhibitory Siglecs for desensitizing mast cells
-
批准号:10219077
-
项目类别:
-
资助金额:$61.27万
-
财政年份:2018
-
负责人:JAMES C PAULSON
-
依托单位:
Exploiting inhibitory Siglecs for desensitizing mast cells
-
批准号:9789823
-
项目类别:
-
资助金额:$61.27万
-
财政年份:2018
-
负责人:JAMES C PAULSON
-
依托单位:
Exploiting inhibitory Siglecs for desensitizing mast cells
-
批准号:10468007
-
项目类别:
-
资助金额:$61.27万
-
财政年份:2018
-
负责人:JAMES C PAULSON
-
依托单位:
Siglec-targeted nanoparticles for treating mast cell mediated allergic disease
-
批准号:10097996
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2018
-
负责人:JAMES C PAULSON
-
依托单位:
Influenza virus receptors on human airway epithelial cells
-
批准号:10226011
-
项目类别:
-
资助金额:$60.62万
-
财政年份:2015
-
负责人:JAMES C PAULSON
-
依托单位:
Influenza virus receptors on human airway epithelial cells
-
批准号:9887570
-
项目类别:
-
资助金额:$62.41万
-
财政年份:2015
-
负责人:JAMES C PAULSON
-
依托单位:
Influenza virus receptors on human airway epithelial cells
-
批准号:8963149
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2015
-
负责人:JAMES C PAULSON
-
依托单位:
Influenza virus receptors on human airway epithelial cells
-
批准号:9233896
-
项目类别:
-
资助金额:$58.58万
-
财政年份:2015
-
负责人:JAMES C PAULSON
-
依托单位:
Influenza virus receptors on human airway epithelial cells
-
批准号:10456119
-
项目类别:
-
资助金额:$60.64万
-
财政年份:2015
-
负责人:JAMES C PAULSON
-
依托单位:
Glycan dependent epitopes of HIV broadly neutralizing antibodies
-
批准号:8777850
-
项目类别:
-
资助金额:$94.75万
-
财政年份:2014
-
负责人:JAMES C PAULSON
-
依托单位:
Glycan dependent epitopes of HIV broadly neutralizing antibodies
-
批准号:9291417
-
项目类别:
-
资助金额:$96.25万
-
财政年份:2014
-
负责人:JAMES C PAULSON
-
依托单位:
Glycan dependent epitopes of HIV broadly neutralizing antibodies
-
批准号:9079346
-
项目类别:
-
资助金额:$96.25万
-
财政年份:2014
-
负责人:JAMES C PAULSON
-
依托单位:
Glycan dependent epitopes of HIV broadly neutralizing antibodies
-
批准号:8892075
-
项目类别:
-
资助金额:$94.75万
-
财政年份:2014
-
负责人:JAMES C PAULSON
-
依托单位:
Inducing antigen specific B cell tolerance
-
批准号:8605833
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2012
-
负责人:JAMES C PAULSON
-
依托单位:
Inducing antigen specific B cell tolerance
-
批准号:8271360
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2012
-
负责人:JAMES C PAULSON
-
依托单位:
Inducing antigen specific B cell tolerance
-
批准号:8423690
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2012
-
负责人:JAMES C PAULSON
-
依托单位:
IN SITU TRANS LIGANDS OF CD22 IDENTIFIED BY GLYCAN-PROTEIN PHOTOCROSS-LINKING
-
批准号:8365790
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2011
-
负责人:JAMES C PAULSON
-
依托单位:
In vivo targeting of hematopoetic cells with glycan ligands of siglecs
-
批准号:8589372
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2009
-
负责人:JAMES C PAULSON
-
依托单位:
海外基金